AHCC and Cancer

Video interview with Geo Espinosa, ND, LAc, CNS

By Tina Kaczor, ND, FABNO

Printer Friendly PagePrinter Friendly Page

Dr. Geovanni Espinosa, director of the Integrative Urological Center at New York University Langone Medical Center, talks with Tina Kaczor, ND, FABNO, about active hexose correlated compound (AHCC) and its use in cancer patients.

Geo Espinosa, ND, LAc, CNS, is the Director of the Integrative Urological Center at New York University Langone Medical Center. He is a licensed naturopathic doctor, licensed acupuncturist, a certified nutrition specialist and a registered herbalist. Dr. Espinosa did his residency/fellowship at Columbia University Medical Center. He is a member of the American Urology Association, the American Herbalist Guild, American Association of Naturopathic Physicians, and American Association of Acupuncture and Oriental Medicine. Dr. Espinosa is an author of the naturopathic entry in 1000 Cures for 200 ailments, and Prostate cancer - Nutrients that may slow its progression in Food and Nutrients in Disease Management.

About the Author

Tina Kaczor, ND, FABNO, is editor-in-chief of Natural Medicine Journal and a naturopathic physician, board certified in naturopathic oncology. She received her naturopathic doctorate from National University of Natural Medicine and completed her residency in naturopathic oncology at Cancer Treatment Centers of America, Tulsa, Oklahoma. Kaczor received undergraduate degrees from the State University of New York at Buffalo. She is the past president and treasurer of the Oncology Association of Naturopathic Physicians and secretary of the American Board of Naturopathic Oncology. She is the editor of the Textbook of Naturopathic Oncology. She has been published in several peer-reviewed journals. Kaczor is based in Portland, Oregon.